Table 3.
Factors associated with low BMD and fracture at multivariate analysis
| |
BMD < −-SD |
Fracture |
||
|---|---|---|---|---|
| OR [95% CI] | P | OR [95% CI] | P | |
| Menopausal female |
13.84 [2.28; 84.11] |
0.004 |
|
|
| Male ≥50 years |
12.2 [1.42; 104.71] |
0.023 |
|
|
| Calcium intake <500 mg/d |
3.98 [1.19; 13.25] |
0.025 |
3.5 [1.09; 11.27] |
0.036 |
| Vitamin D supplements |
12.86 [2.98; 55.53] |
0.001 |
|
|
| BP treatment |
4.6 [1.47; 14.3 ] |
0.009 |
|
|
| Fracture |
3.88 [0.99 ;15.23] |
0.052 |
|
|
| 25(OH)D ≤10 ng/ml |
1 |
- |
1 |
- |
| 10 < 25(OH)D ≤20 ng/ml |
0.29 [0.08; 1.06] |
0.062 |
2.05 [0.57; 7.45] |
0.274 |
| 25(OH)D >20 ng/ml |
0.96 [0.25; 3.67] |
0.95 |
3.93 [1.02; 15.17] |
0.047 |
| Current CS treatment |
|
|
3.73 [1.06; 13.16] |
0.04 |
| Creatinine clearance | 0,97 [0.94; 0.99] | 0.002 | ||
BMD, Bone mineral density; BP, Bisphosphonate; CS, Corticosteroids. Empty cells correspond to variables not included in the multivariate analysis because they were not significant at univariate analysis or to variables included in the multivariate analysis but not retained in the final model because they were no longer significant (for example, age).